Ion Channel Dysfunction and Therapeutic Targeting in Salivary Gland Disorders
Oral Diseases · 2026-10 · 32 (10) · 3050-3067
DOI: 10.1111/odi.70419 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oral Diseases, online erschienen am 05.07.2026. Verfasst von Tarek Mohamed Abd El-Aziz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Regenerative Sciences, School of Dentistry, University of Texas Health Science Center San Antonio, San Antonio, Texas, USA. Hauptthemen laut MEDLINE: Salivary Gland Diseases, Ion Channels. Die Arbeit nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Objective
Salivary gland hypofunction and xerostomia represent major clinical complications of radiation therapy, autoimmune disorders such as Sjögren's disease, and inherited epithelial ion transport defects. This review integrates current knowledge on ion channel dysfunction as a central mechanistic driver of salivary gland pathology and evaluates promising ion channel‐targeted therapeutic strategies.
Methods
A comprehensive narrative review was performed using PubMed, Scopus, and Web of Science to identify experimental, translational, and clinical studies on ion channel regulation in salivary gland physiology and disease.
Results
Salivary secretion depends on coordinated Ca 2+ signaling and polarized ion transport in acinar and ductal cells. Across radiation injury, Sjögren's disease, and cystic fibrosis, disease‐specific disruptions of calcium entry, chloride conductance, and water channel trafficking converge on impaired fluid secretion through distinct but mechanistically overlapping pathways. These insights have driven targeted therapies, including muscarinic agonists, ANO1 and CFTR modulators, anti‐inflammatory strategies, and AAV2‐hAQP1 gene therapy, which shows sustained benefit in radiation‐induced xerostomia.
Conclusions
Ion channels are central regulators of salivary gland physiology and promising therapeutic targets, and combining pharmacologic, gene, and regenerative approaches provides a precision strategy to restore salivary gland function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Regenerative Sciences, School of Dentistry, University of Texas Health Science Center San Antonio, San Antonio, Texas, USA.
- Zoology Department, Faculty of Science, Minia University, El-Minia, Egypt.
- Department of Biology, Faculty of Education and Arts, Sohar University, Sohar, Sultanate of Oman.
- College of Integrative Studies, Abdullah Al Salem University, Khaldiya, Kuwait.
ORCID-Profile: Tarek Mohamed Abd El-Aziz
Förderung
- NIDCR NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Abd El-Aziz, T. M., Varadarajan, S. N., Drel, V., Arullampalam, P., Shoulkamy, M. I., Al-Sabi, A., & Singh, B. B. (2026). Ion Channel Dysfunction and Therapeutic Targeting in Salivary Gland Disorders. Oral Diseases, 32(10), 3050-3067. https://doi.org/10.1111/odi.70419
Vancouver
Abd El-Aziz TM, Varadarajan SN, Drel V, Arullampalam P, Shoulkamy MI, Al-Sabi A, et al. Ion Channel Dysfunction and Therapeutic Targeting in Salivary Gland Disorders. Oral Diseases. 2026;32(10):3050-3067. doi:10.1111/odi.70419
BibTeX
@article{AbdElAziz2026,
author = {Abd El-Aziz, Tarek Mohamed and Varadarajan, Shankara N and Drel, Viktor and Arullampalam, Prakash and Shoulkamy, Mahmoud I and Al-Sabi, Ahmed and Singh, Brij B},
title = {Ion Channel Dysfunction and Therapeutic Targeting in Salivary Gland Disorders},
journal = {Oral Diseases},
year = {2026},
volume = {32},
number = {10},
pages = {3050--3067},
doi = {10.1111/odi.70419}
}
EUVIMED